Annual report pursuant to Section 13 and 15(d)

Condensed Consolidating Statements of Cash Flows (Detail)

v2.4.0.8
Condensed Consolidating Statements of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Aug. 31, 2013
Aug. 31, 2012
Aug. 31, 2011
Operating activities      
Net cash provided by operating activities $ 193,789 $ 182,329 $ 171,566
Investing activities      
Proceeds from sale of property, plant and equipment 1,621 8,501 1,779
Proceeds from sale of business 4,854 0 3,463
Capital expenditures (23,668) (22,740) (23,096)
Business acquisitions, net of cash acquired (235,489) (69,309) (313,106)
Cash used in investing activities (252,682) (83,548) (330,960)
Financing activities      
Net borrowings on revolving credit facilities 125,000 (58,167) 58,204
Proceeds from issuance of term loans 0 0 100,000
Intercompany loan activity 0 0 0
Repayment Of Term Loan 7,500 2,500 0
Repurchases of 2% Convertible Notes 0 (102) (34)
Proceeds from issuance of 5.625% Senior Notes 0 300,000 0
Redemption of 6.875% Senior Notes 0 (250,000) 0
Payment of deferred acquisition consideration (5,378) (958) (350)
Debt issuance costs (2,035) (5,490) (5,197)
Purchase of treasury shares (41,832) (63,083) 0
Stock option exercises and related tax benefits 33,261 10,913 8,235
Cash dividend (2,911) (2,748) (2,716)
Cash provided by (used in) financing activities 98,605 (72,135) 158,142
Effect of exchange rate changes on cash (3,910) (2,683) 5,251
Net increase in cash and cash equivalents 35,802 23,963 3,999
Cash and cash equivalents—beginning of year 68,184 44,221 40,222
Cash and cash equivalents—end of year 103,986 68,184 44,221
Parent
      
Operating activities      
Net cash provided by operating activities 81,597 97,454 92,573
Investing activities      
Proceeds from sale of property, plant and equipment 563 1,909 103
Proceeds from sale of business 0   0
Capital expenditures (2,022) (5,062) (5,284)
Business acquisitions, net of cash acquired 0 0 (153,409)
Cash used in investing activities (1,459) (3,153) (158,590)
Financing activities      
Net borrowings on revolving credit facilities 125,000 (57,990) 58,000
Proceeds from issuance of term loans     100,000
Intercompany loan activity (179,050) (11,482) (96,454)
Repayment Of Term Loan 7,500 2,500  
Repurchases of 2% Convertible Notes   (102) (34)
Proceeds from issuance of 5.625% Senior Notes   300,000  
Redemption of 6.875% Senior Notes   (250,000)  
Payment of deferred acquisition consideration (1,350) (290) 0
Debt issuance costs (2,035) (5,490) (5,197)
Purchase of treasury shares (41,832) (63,083)  
Stock option exercises and related tax benefits 33,261 10,913 8,235
Cash dividend (2,911) (2,748) (2,716)
Cash provided by (used in) financing activities (76,417) (82,772) 61,834
Effect of exchange rate changes on cash 0 0 0
Net increase in cash and cash equivalents 3,721 11,529 (4,183)
Cash and cash equivalents—beginning of year 12,401 872 5,055
Cash and cash equivalents—end of year 16,122 12,401 872
Guarantors
      
Operating activities      
Net cash provided by operating activities 26,095 20,363 3,122
Investing activities      
Proceeds from sale of property, plant and equipment 206 353 313
Proceeds from sale of business 0   0
Capital expenditures (4,021) (4,069) (4,740)
Business acquisitions, net of cash acquired 0 0 0
Cash used in investing activities (3,815) (3,716) (4,427)
Financing activities      
Net borrowings on revolving credit facilities 0 0 0
Proceeds from issuance of term loans     0
Intercompany loan activity (22,371) (16,556) 1,655
Repayment Of Term Loan 0 0  
Repurchases of 2% Convertible Notes   0 0
Proceeds from issuance of 5.625% Senior Notes   0  
Redemption of 6.875% Senior Notes   0  
Payment of deferred acquisition consideration 0 0 (350)
Debt issuance costs 0 0 0
Purchase of treasury shares 0 0  
Stock option exercises and related tax benefits 0 0 0
Cash dividend 0 0 0
Cash provided by (used in) financing activities (22,371) (16,556) 1,305
Effect of exchange rate changes on cash 0 0 0
Net increase in cash and cash equivalents (91) 91 0
Cash and cash equivalents—beginning of year 91 0 0
Cash and cash equivalents—end of year 0 91 0
Non-Guarantors
      
Operating activities      
Net cash provided by operating activities 86,097 64,512 77,404
Investing activities      
Proceeds from sale of property, plant and equipment 852 6,239 1,363
Proceeds from sale of business 4,854   3,463
Capital expenditures (17,625) (13,609) (13,072)
Business acquisitions, net of cash acquired (235,489) (69,309) (159,697)
Cash used in investing activities (247,408) (76,679) (167,943)
Financing activities      
Net borrowings on revolving credit facilities 0 (177) 204
Proceeds from issuance of term loans     0
Intercompany loan activity 201,421 28,038 94,799
Repayment Of Term Loan 0 0  
Repurchases of 2% Convertible Notes   0 0
Proceeds from issuance of 5.625% Senior Notes   0  
Redemption of 6.875% Senior Notes   0  
Payment of deferred acquisition consideration (4,028) (668) 0
Debt issuance costs 0 0 0
Purchase of treasury shares 0 0  
Stock option exercises and related tax benefits 0 0 0
Cash dividend 0 0 (1,533)
Cash provided by (used in) financing activities 197,393 27,193 93,470
Effect of exchange rate changes on cash (3,910) (2,683) 5,251
Net increase in cash and cash equivalents 32,172 12,343 8,182
Cash and cash equivalents—beginning of year 55,692 43,349 35,167
Cash and cash equivalents—end of year 87,864 55,692 43,349
Eliminations
      
Operating activities      
Net cash provided by operating activities 0 0 (1,533)
Investing activities      
Proceeds from sale of property, plant and equipment 0 0 0
Proceeds from sale of business 0   0
Capital expenditures 0 0 0
Business acquisitions, net of cash acquired 0 0 0
Cash used in investing activities 0 0 0
Financing activities      
Net borrowings on revolving credit facilities 0 0 0
Proceeds from issuance of term loans     0
Intercompany loan activity 0 0 0
Repayment Of Term Loan 0 0  
Repurchases of 2% Convertible Notes   0 0
Proceeds from issuance of 5.625% Senior Notes   0  
Redemption of 6.875% Senior Notes   0  
Payment of deferred acquisition consideration 0 0 0
Debt issuance costs 0 0 0
Purchase of treasury shares 0 0  
Stock option exercises and related tax benefits 0 0 0
Cash dividend 0 0 1,533
Cash provided by (used in) financing activities 0 0 1,533
Effect of exchange rate changes on cash 0 0 0
Net increase in cash and cash equivalents 0 0 0
Cash and cash equivalents—beginning of year 0 0 0
Cash and cash equivalents—end of year $ 0 $ 0 $ 0